Filter Posts:
- All
- Ginkgo in the News
- Press Releases
November 16, 2022
Ginkgo Announces Public Offering of Class A Common Stock
Ginkgo PressNovember 15, 2022
Ginkgo Bioworks Announces Proposed Public Offering of Class A Common Stock
Ginkgo PressNovember 14, 2022
Ginkgo Bioworks Reports Third Quarter 2022 Financial Results
Ginkgo PressNovember 11, 2022
Lygos and Ginkgo Bioworks Announce Partnership to Optimize Production of Biobased Specialty Chemicals
Ginkgo PressNovember 9, 2022
Ginkgo Bioworks To Present New Data on High Throughput Pooled Screening Method to Discover Novel CAR-T Designs for Solid Tumors
Ginkgo PressNovember 7, 2022
Ginkgo Bioworks Announces Date of Third Quarter 2022 Results Presentation
Ginkgo PressOctober 25, 2022
Ginkgo Bioworks and the Ministry of Investment of Saudi Arabia Announce Plans to Develop Biosecurity and Biotechnology Capabilities for Global Public Health
Ginkgo PressOctober 20, 2022
Bolt Threads Announces Latest Collaboration with Ginkgo Bioworks to Optimize its Mylo™ Material
Ginkgo PressOctober 19, 2022
Ginkgo Bioworks Completes Acquisition of Zymergen
Ginkgo Press
October 18, 2022
Bayer and Ginkgo Bioworks close deal creating Agricultural Biologicals Powerhouse
Ginkgo PressOctober 17, 2022
IARPA, Ginkgo Bioworks and Draper Announce New Technologies to Detect Engineered DNA
Ginkgo PressOctober 11, 2022
Ginkgo Bioworks Announces Collaboration with Merck to Improve Active Pharmaceutical Ingredient Manufacturing
Ginkgo PressOctober 11, 2022
Ginkgo Bioworks Announces Collaboration with Merck to Improve Active Pharmaceutical Ingredient Manufacturing
Ginkgo PressOctober 4, 2022
Ginkgo Bioworks Acquires Circularis to Strengthen Capabilities in Cell and Gene Therapy
Ginkgo PressOctober 4, 2022
Ginkgo Bioworks Acquires Adaptive Laboratory Evolution Company Altar
Ginkgo PressSeptember 12, 2022
Renee Wegrzyn Slated to Lead New Advanced Research Projects Agency for Health
Ginkgo PressSeptember 1, 2022
Ginkgo Bioworks Appoints Dr. Behzad Mahdavi as Senior Vice President of Biopharma Manufacturing & Life Science Tools
Ginkgo PressAugust 19, 2022
Ginkgo Bioworks Announces Strategic Purchase of Epidemiological Data Infrastructure Assets
Ginkgo PressAugust 15, 2022
Ginkgo Bioworks Reports Second Quarter 2022 Financial Results
Ginkgo PressAugust 15, 2022
Ginkgo Bioworks Reports Second Quarter 2022 Financial Results
Ginkgo PressAugust 15, 2022
Ginkgo Bioworks and XpresCheck Receive Award to Expand CDC’s Traveler-Based SARS-CoV-2 Genomic Surveillance Program In U.S. Airports
Ginkgo PressAugust 11, 2022
Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks
Ginkgo PressAugust 11, 2022
Ginkgo Bioworks and the Rwanda Development Board Announce Plans to Develop and Implement New Biosecurity Capabilities in Rwanda
Ginkgo PressAugust 8, 2022
Ginkgo Bioworks Announces Date of Second Quarter 2022 Results Presentation
Ginkgo PressAugust 4, 2022
Ginkgo Bioworks Appoints Kathy Hopinkah Hannan to its Board of Directors
Ginkgo PressJuly 28, 2022
Clinical Enterprise, Inc. and Ginkgo Bioworks to Continue Support of Federal COVID-19 Testing Program Through 2022
EurofinsJuly 25, 2022
Ginkgo to Acquire Zymergen
Ginkgo PressJuly 25, 2022
Ginkgo and Bayer Sign Definitive Agreement to Build Agricultural Biologicals R&D Platform Capabilities
Ginkgo PressJuly 18, 2022
Ginkgo Bioworks Announces Latest Collaboration for Beauty and Personal Care Industry with Sumitomo Chemical
Ginkgo PressJuly 14, 2022
Ginkgo Bioworks Publishes Inaugural Sustainability Report
Ginkgo PressJune 24, 2022
Concentric by Ginkgo crosses 10 million samples tested and expands testing and sequencing capabilities to detect monkeypox and other pathogens, as part of scaling its global biosecurity infrastructure
Ginkgo PressJune 21, 2022
Cronos Group and Ginkgo Bioworks Announce Achievement of THCV Equity Milestone
Ginkgo PressJune 10, 2022
Ginkgo Bioworks Announces Participation in Goldman Sachs 43rd Annual Global Healthcare Conference
Ginkgo PressJune 7, 2022
Ginkgo Bioworks and Novo Nordisk to Collaborate on Expression Systems for Pharmaceutical Products
Ginkgo PressJune 6, 2022
Ginkgo Bioworks Acquires Bitome, an Integrated Metabolite Monitoring Platform
Ginkgo PressJune 2, 2022
Ginkgo Bioworks Announces Participation in William Blair’s 42nd Annual Growth Stock Conference
Ginkgo PressMay 18, 2022
Ginkgo Bioworks and First Serv Announce Plans to Develop and Implement Innovative Global Biosecurity Capabilities in Qatar
Ginkgo PressMay 16, 2022
Ginkgo Bioworks Reports First Quarter 2022 Financial Results
Ginkgo PressMay 16, 2022
Ginkgo Bioworks Reports First Quarter 2022 Financial Results
Ginkgo PressMay 9, 2022
Ginkgo Bioworks Announces Date of First Quarter 2022 Results Presentation
Ginkgo PressApril 22, 2022
Ginkgo Bioworks to Expand Platform Capabilities in Agricultural Biologicals and Launch Flagship Partnership with Bayer
Ginkgo PressApril 14, 2022
Light Bio Partners with Ginkgo Bioworks to Optimize the Brightness of Glowing Plants through Bioluminescence Engineering
GinkgoApril 14, 2022
Light Bio Partners with Ginkgo Bioworks to Optimize the Brightness of Glowing Plants through Bioluminescence Engineering
Ginkgo PressApril 13, 2022
FREDsense and Ginkgo Bioworks Announce Partnership to Develop Water Quality Biosensors
Ginkgo PressApril 12, 2022
Persephone Biosciences and Ginkgo Bioworks Announce Collaboration to Develop Novel Therapeutics
Ginkgo PressApril 11, 2022
Elanco and Ginkgo Bioworks Launch BiomEdit, a New Animal Health Company Leveraging Microbiome Technology
GinkgoApril 11, 2022
Elanco and Ginkgo Bioworks Launch BiomEdit, a New Animal Health Company Leveraging Microbiome Technology
Ginkgo PressApril 5, 2022
Twist Bioscience and Ginkgo Bioworks Sign New Collaboration
TwistApril 4, 2022
Microba Life Sciences and Ginkgo Bioworks Announce Partnership to Discover Novel Live Biotherapeutics
Ginkgo PressMarch 28, 2022
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2021 Financial Results
Ginkgo PressMarch 28, 2022
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2021 Financial Results
Ginkgo PressMarch 23, 2022
CDC, Concentric by Ginkgo and XpresCheck® Publish Results of CDC COVID-19 Air Travel Biosecurity Program at International Airports
Ginkgo PressMarch 17, 2022
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2021 Results Presentation and Date for Annual Meeting of Shareholders
Ginkgo PressMarch 15, 2022
Ginkgo Bioworks Announces Participation in Jefferies Virtual Synthetic Biology Week
Ginkgo PressMarch 14, 2022
Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platform
Ginkgo PressFebruary 28, 2022
Phytolon and Ginkgo Bioworks Collaborate to Take Biological Production of Vibrant Food Colors to the Next Level
PhytolonFebruary 24, 2022
Ginkgo Bioworks Announces Participation in Upcoming Conferences
Ginkgo PressFebruary 8, 2022
Ginkgo Bioworks Announces Participation in Upcoming Conferences
Ginkgo PressJanuary 19, 2022
Ginkgo Bioworks Announces Acquisition of Massachusetts COVID-19 Testing Provider Project Beacon COVID-19 LLC
Ginkgo PressJanuary 12, 2022
Ginkgo Bioworks Provides Preliminary Unaudited 2021 Revenue Highlights and Business Review
Ginkgo PressJanuary 10, 2022
Selecta Biosciences and Ginkgo Bioworks Announce New Collaboration to Develop Next-Generation Gene Therapy Capsids
Ginkgo PressJanuary 6, 2022
Optimvia and Ginkgo Bioworks Announce Partnership to Manufacture Biosynthetic Heparin
OptimviaJanuary 6, 2022
Optimvia and Ginkgo Bioworks Announce Partnership to Manufacture Biosynthetic Heparin
Ginkgo PressJanuary 5, 2022
Ginkgo Bioworks Announces Participation in 40th Annual J.P. Morgan Healthcare Conference
Ginkgo PressDecember 20, 2021
Benjamin Franklin Institute of Technology, Ginkgo Bioworks to Launch Biotechnology Manufacturing Associates Degree
Ginkgo PressDecember 18, 2021
Concentric by Ginkgo and XpresCheck™ Confirm First North American Detections of Novel BA.3 Sublineage of Omicron Variant through CDC COVID-19 Air Travel Biosecurity Program
Ginkgo PressDecember 13, 2021
Eurofins’ Clinical Enterprise Launches New Partnership with Ginkgo Bioworks to Support Federally Funded COVID-19 PCR Testing Program
EurofinsDecember 7, 2021
Concentric by Ginkgo Confirms Detection of Omicron Variant through COVID-19 Air Travel Biosecurity Collaboration with CDC and XpresCheck
GinkgoDecember 7, 2021
Concentric by Ginkgo Confirms Detection of Omicron Variant through COVID-19 Air Travel Biosecurity Collaboration with CDC and XpresCheck
Ginkgo PressNovember 30, 2021
XpresSpa Group and Ginkgo Bioworks Collaboration with the Centers for Disease Control and Prevention (CDC) COVID-19 Biosurveillance Program Expands to Include Detection of the New Omicron Variant
XpresSpa GroupNovember 30, 2021
XpresSpa Group and Ginkgo Bioworks Collaboration with the Centers for Disease Control and Prevention (CDC) COVID-19 Biosurveillance Program Expands to Include Detection of the New Omicron Variant
Ginkgo PressNovember 24, 2021
Ginkgo Bioworks Announces Participation in Upcoming Conferences
GinkgoNovember 24, 2021
Ginkgo Bioworks Announces Participation in Upcoming Conferences
Ginkgo PressNovember 17, 2021
mRNA Victoria and Ginkgo Bioworks Announce Partnership to Grow the Bioeconomy & International Biosecurity Capabilities
GinkgoNovember 17, 2021
mRNA Victoria and Ginkgo Bioworks Announce Partnership to Grow the Bioeconomy & International Biosecurity Capabilities
Ginkgo PressNovember 15, 2021
Ginkgo Bioworks Reports Third Quarter 2021 Results
GinkgoNovember 15, 2021
Ginkgo Bioworks Reports Third Quarter 2021 Results
Ginkgo PressNovember 15, 2021
Ginkgo Bioworks Reports Third Quarter 2021 Results
Ginkgo PressNovember 11, 2021
Ginkgo Bioworks Launches Cell Development Kit Service for Standardized, Low-Cost Entry to its Cell Programming Platform
GinkgoNovember 11, 2021
Ginkgo Bioworks Launches Cell Development Kit Service for Standardized, Low-Cost Entry to its Cell Programming Platform
Ginkgo PressNovember 9, 2021
Synlogic and Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine for the Treatment of Homocystinuria
SynlogicNovember 9, 2021
Synlogic and Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine for the Treatment of Homocystinuria
Ginkgo PressNovember 9, 2021
Ginkgo Bioworks Announces Date of Third Quarter 2021 Results Presentation
GinkgoNovember 8, 2021
Ginkgo Bioworks Announces Date of Third Quarter 2021 Results Presentation
Ginkgo PressOctober 28, 2021
Ginkgo Bioworks Previews Today’s Annual Ferment Conference
FermentOctober 28, 2021
Ginkgo Bioworks Previews Today’s Annual Ferment Conference
Ginkgo PressOctober 27, 2021
Arcaea, a Company Launched on the Ginkgo Bioworks Platform, Announces $78M Series A To Build a New Foundation For the Beauty Industry through Expressive Biology
ArcaeaOctober 27, 2021
Arcaea, a Company Launched on the Ginkgo Bioworks Platform, Announces $78M Series A To Build a New Foundation For the Beauty Industry through Expressive Biology
Ginkgo PressOctober 26, 2021
Selecta Biosciences and Ginkgo Bioworks Announce Partnership to Advance Treatments for Orphan and Rare Diseases
SelectaOctober 26, 2021
Selecta Biosciences and Ginkgo Bioworks Announce Partnership to Advance Treatments for Orphan and Rare Diseases
Ginkgo PressOctober 20, 2021
Quest Diagnostics to Provide K-12 School COVID-19 Testing in Collaboration with Ginkgo Bioworks to Support Safer Classroom Learning in Texas for New Statewide School Testing Program
QuestOctober 20, 2021
Quest Diagnostics to Provide K-12 School COVID-19 Testing in Collaboration with Ginkgo Bioworks to Support Safer Classroom Learning in Texas for New Statewide School Testing Program
Ginkgo PressOctober 20, 2021
Ginkgo Bioworks Announces Participation in Jefferies Gene Therapy/Editing Summit
Ginkgo PressSeptember 30, 2021
Ginkgo Bioworks Announces Participation in Upcoming Conferences
GinkgoSeptember 30, 2021
Ginkgo Bioworks Announces Participation in Upcoming Conferences
Ginkgo PressSeptember 24, 2021
Ginkgo Bioworks Expands Commitment at Marcus Partners Life Science Campus at Parcels O & P in Raymond L. Flynn Marine Park
Marcus PartnersSeptember 17, 2021
Ginkgo Bioworks CEO Jason Kelly on the business of programmable DNA
CNBC Squawk on the StreetSeptember 17, 2021
Ginkgo Bioworks to Begin Trading Today as NYSE: DNA with Over $1.6 Billion in Proceeds
$DNASeptember 17, 2021
Ginkgo Bioworks to Begin Trading Today as NYSE: DNA with Over $1.6 Billion in Proceeds
Ginkgo PressSeptember 14, 2021
Ginkgo Bioworks to Go Public with Over $1.6 Billion in Proceeds
Soaring EagleSeptember 14, 2021
Ginkgo Bioworks to Go Public with Over $1.6 Billion in Proceeds
Ginkgo PressSeptember 14, 2021
Africa CDC and Ginkgo Bioworks Announce Collaboration to Strengthen Laboratory Network Capacity Across African Union Member States
Africa CDCSeptember 14, 2021
Africa CDC and Ginkgo Bioworks Announce Collaboration to Strengthen Laboratory Network Capacity Across African Union Member States
Ginkgo PressSeptember 10, 2021
Concentric by Ginkgo Stands Ready to Continue Fighting Pandemic, Providing Biosecurity and COVID Testing Nationwide to Schools, Workplaces, and Other Congregate Settings
Ginkgo PressSeptember 10, 2021
Concentric by Ginkgo Stands Ready to Continue Fighting Pandemic, Providing Biosecurity and COVID Testing Nationwide to Schools, Workplaces, and Other Congregate Settings
ConcentricSeptember 10, 2021
New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant Platform and Forms Collaboration with Ginkgo Bioworks
SaponiQxSeptember 10, 2021
New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant Platform and Forms Collaboration with Ginkgo Bioworks
Ginkgo PressSeptember 9, 2021
Ginkgo Bioworks’ Ferment Consortium Launches Ayana Bio to Produce Plant and Fungal Bioactives for Herbal Medicines and Nutraceuticals
Ginkgo BioworksSeptember 9, 2021
Ginkgo Bioworks’ Ferment Consortium Launches Verb Biotics, a Probiotics Innovation Company to Address Market Demands for Effective Probiotics
Ginkgo PressSeptember 9, 2021
Ginkgo Bioworks’ Ferment Consortium Launches Ayana Bio to Produce Plant and Fungal Bioactives for Herbal Medicines and Nutraceuticals
Ginkgo PressSeptember 7, 2021
Tantu and Ginkgo Bioworks Announce Partnership to Engineer a Living Biotherapeutic for Gastrointestinal Healing
Ginkgo PressSeptember 3, 2021
Cambium Biomaterials Announces Partnership with Ginkgo Bioworks to Accelerate Industrial Adoption of High-Performance Biomaterials
CambiumSeptember 3, 2021
Ginkgo Bioworks Announces Participation In Upcoming Virtual Conferences
Ginkgo PressSeptember 3, 2021
Cambium Biomaterials Announces Partnership with Ginkgo Bioworks to Accelerate Industrial Adoption of High-Performance Biomaterials
Ginkgo PressSeptember 2, 2021
Cambium Biomaterials Announces Partnership with Ginkgo Bioworks to Accelerate Industrial Adoption of High-Performance Biomaterials
Ginkgo PressAugust 30, 2021
Ginkgo Bioworks and Givaudan Enter Multi-Program Collaboration to Produce a Series of Ingredients
Ginkgo BioworksAugust 30, 2021
Ginkgo Bioworks and Givaudan Enter Multi-Program Collaboration to Produce a Series of Ingredients
Ginkgo PressAugust 23, 2021
Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured Cannabinoids
Cronos GroupAugust 23, 2021
Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured Cannabinoids
Ginkgo PressAugust 19, 2021
Using synthetic biology platforms to clean up indigo dye-making
AxiosAugust 19, 2021
Huue and Ginkgo Bioworks Partner to Accelerate Production of Sustainable Dyes
HuueAugust 19, 2021
Huue and Ginkgo Bioworks Partner to Accelerate Production of Sustainable Dyes
Ginkgo PressAugust 18, 2021
Ginkgo Bioworks Provides First Half 2021 Update
Ginkgo BioworksAugust 18, 2021
Ginkgo Bioworks Provides First Half 2021 Update
Ginkgo PressAugust 13, 2021
Soaring Eagle Announces Extraordinary General Meeting Date for Proposed Business Combination with Ginkgo
BusinesswireAugust 13, 2021
XpresSpa Group™ Receives Approval for a $2 Million Program with the Centers for Disease Control and Prevention (CDC) for Biosurveillance Tracking in Collaboration with Concentric by Ginkgo at Three Major U.S. Airports
GlobeNewswireAugust 12, 2021
Out to revamp plant-based drug manufacturing, Antheia locks in partnership with synthetic biology giant Ginkgo
EndpointsAugust 12, 2021
Antheia and Ginkgo Bioworks Announce Partnership to Accelerate Production of Essential Medicines using Synthetic Biology
AntheiaAugust 12, 2021
Antheia and Ginkgo Bioworks Announce Partnership to Accelerate Production of Essential Medicines using Synthetic Biology
Ginkgo PressAugust 11, 2021
Ginkgo Bioworks and Soaring Eagle Acquisition Corp. Announce Effectiveness of Form S-4 Registration Statement
Ginkgo BioworksAugust 11, 2021
Ginkgo Bioworks and Soaring Eagle Acquisition Corp. Announce Effectiveness of Form S-4 Registration Statement
Ginkgo PressAugust 10, 2021
Ginkgo and Aldevron tout mRNA manufacturing ‘breakthrough’—and the perks could stretch well beyond COVID-19, exec says
Fierce PharmaAugust 10, 2021
Aldevron’s Collaboration with Ginkgo Bioworks Yields Manufacturing Breakthrough for Vaccinia Capping Enzyme Used for Manufacturing of mRNA Vaccines
AldevronAugust 10, 2021
Aldevron’s Collaboration with Ginkgo Bioworks Yields Manufacturing Breakthrough for Vaccinia Capping Enzyme Used for Manufacturing of mRNA Vaccines
Ginkgo PressAugust 9, 2021
Ginkgo Bioworks Announces Date of First Half 2021 Results Presentation
Ginkgo PressAugust 7, 2021
Bolt Threads and Ginkgo Bioworks collaborate on cosmetics
C&ENAugust 5, 2021
Bolt Threads to Leverage Ginkgo Bioworks’ Platform for Commercial Strain Optimization of b-silk™ Protein
Bolt ThreadsAugust 5, 2021
Bolt Threads to Leverage Ginkgo Bioworks’ Platform for Commercial Strain Optimization of b-silk™ Protein
Ginkgo PressAugust 3, 2021
Vertex CEO Reshma Kewalramani, MD to join Ginkgo Bioworks Board of Directors
Ginkgo BioworksAugust 3, 2021
Vertex CEO Reshma Kewalramani, MD to join Ginkgo Bioworks Board of Directors
Ginkgo PressJuly 29, 2021
Ginkgo Bioworks Announces Participation in Upcoming Conferences
Ginkgo BioworksJuly 29, 2021
Ginkgo Bioworks Announces Participation in Upcoming Conferences
Ginkgo PressJuly 8, 2021
What is it really like to take your company public via a SPAC? One Boston biotech shares its journey
FortuneJuly 3, 2021
Ginkgo Bioworks CEO Jason Kelly
This Week In StartupsJune 22, 2021
Taking DNA to the Street
Boston GlobeJune 10, 2021
New Hampshire Department of Health and Human Services Brings Pooled Testing to K-12 Classrooms in Partnership with Concentric by Ginkgo
Ginkgo PressJune 10, 2021
New Hampshire Department of Health and Human Services Brings Pooled Testing to K-12 Classrooms in Partnership with Concentric by Ginkgo
Ginkgo BioworksJune 7, 2021
Ginkgo Bioworks Announces R&D Collaboration with Sumitomo Chemical to Develop More Sustainable Bio-Based Chemicals for Multiple Industries
Ginkgo PressJune 4, 2021
Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Begins Commercial Production of CBG
CronosJune 4, 2021
Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Begins Commercial Production of CBG
Ginkgo PressJune 3, 2021
The promise and peril of engineering biology, w/Ginkgo Bioworks Reshma Shetty
Masters of Scale PodcastMay 24, 2021
Ginkgo Bioworks Announces Investor Day and Participation in Upcoming Investor Conferences
Ginkgo PressMay 21, 2021
Biogen and Ginkgo Bioworks Announce Collaboration and License Agreement to Develop Novel Gene Therapy Manufacturing Platform
Ginkgo PressMay 21, 2021
Biogen and Ginkgo Bioworks Partner to Redefine AAV-Based Vector Manufacturing
BiospaceMay 21, 2021
Biogen and Ginkgo Bioworks Announce Collaboration and License Agreement to Develop Novel Gene Therapy Manufacturing Platform
BiogenMay 17, 2021
Ginkgo tees up its next acquisition just days after inking $2.5B SPAC deal
Fierce BiotechMay 17, 2021
Ginkgo Bioworks Announces Agreement to Acquire Fungal Platform Technology Company Dutch DNA
Ginkgo PressMay 11, 2021
Ginkgo Bioworks resizes the definition of going big in biotech, raising $2.5B in a record SPAC deal that weighs in with a whopping $15B-plus valuation
EndpointsMay 11, 2021
Ginkgo Bioworks to Become a Public Company and Expand its Leading Platform for Cell Programming
Ginkgo PressApril 22, 2021
Dylan George joins Ginkgo Bioworks to grow the company’s global biosecurity efforts
Ginkgo BioworksApril 3, 2021
Bioengineering stronger crops that can survive extreme weather
AxiosApril 2, 2021
Ginkgo Bioworks aims to keep growing with new building in the Seaport
Boston GlobeApril 1, 2021
Corteva Agriscience Collaborates with Ginkgo Bioworks to Bolster Crop Protection
Ginkgo BioworksMarch 26, 2021
Unlocking the COVID code
The New York TimesMarch 25, 2021
From antipasti to antivirals: Ginkgo’s quiet quest to remake how mRNA vaccines are made
EndpointsMarch 20, 2021
Schools already testing students and staff for coronavirus say it’s crucial to in-person class: ‘It’s worth it’
USA TodayMarch 10, 2021
1 big thing: Schools bet on pool testing to keep classrooms safe
AxiosMarch 9, 2021
The Ten Most Innovative Joint Ventures 2021
Fast CompanyMarch 4, 2021
Massachusetts Actually Might Have a Way to Keep Schools Open
The AtlanticFebruary 23, 2021
Massachusetts software engineer launches Twitter account to find coronavirus vaccine slots
Boston HeraldFebruary 4, 2021
State set to begin pool testing to get kids back in the classroom
Fox 25 BostonFebruary 4, 2021
COVID-19 pool testing underway at Massachusetts schools
WCVBFebruary 2, 2021
Ginkgo Bioworks Selected to Provide Pooled COVID-19 Testing for Massachusetts K-12 Schools
Pooled Testing for K12January 22, 2021
Strength in numbers? The future of COVID-19 testing may depend on it
Boston GlobeDecember 23, 2020
Ginkgo Bioworks Launches COVID-19 Pooled Classroom Testing Pilot for K-12 Schools
Ginkgo BioworksDecember 21, 2020
Biotech companies unite to engineer a better mosquito repellent
AxiosDecember 17, 2020
Ginkgo Bioworks, Azitra, Florida International University, and Latham BioPharm Group Awarded $15M by DARPA to Develop Skin Microbiome-based Mosquito Repellent
RevectorDecember 16, 2020
Ginkgo Bioworks Acquires Biotechnology Startup Novogy’s Microbial Engineering Platform
NovogyDecember 10, 2020
Ginkgo Bioworks and Octant Partner to Expand COVID-19 Testing Capacity using Next-Generation Sequencing Technology
OctantDecember 10, 2020
Why your kids’ schools could stay open this winter if we ramped up COVID-19 testing
USA TodayDecember 7, 2020
Inside Ginkgo Bioworks’ efforts to dramatically scale Covid-19 testing
Boston Business JournalDecember 1, 2020
Ginkgo Bioworks CEO on $1.1 billion loan for coronavirus efforts
CNBCNovember 25, 2020
U.S loans $1.1 billion to Ginkgo Bioworks for pandemic effort
ReutersNovember 25, 2020
Ginkgo Bioworks To Expand Biosecurity and Pandemic Response Platform with $1.1B Federal Loan
DFCNovember 20, 2020
Ginkgo Bioworks Funds Expansion of Rapid Antigen Test Manufacturing with Access Bio in New Jersey
AccessBioNovember 3, 2020
‘The Biological Event Of Our Lives’: Boston Biotech Unicorn Dives Into Mass Coronavirus Testing
WBUROctober 29, 2020
Allonnia launches to destroy pollution with microbes
C&ENOctober 26, 2020
Ginkgo Bioworks Secures Access to SARS-CoV-2 Rapid Antigen Test With Goal of Acquiring and Distributing Up To 50 Million Tests
Rapid Antigen TestsOctober 22, 2020
Allonnia Launches from Ginkgo Bioworks’ Ferment Consortium with $40M Series A to Address Critical Problems in Waste Remediation with Synthetic Biology, Appoints Nicole Richards as CEO
AllonniaOctober 22, 2020
Bill Gates backed venture aims to eliminate forever chemicals
BloombergOctober 22, 2020
Eyeing big testing expansion, Ginkgo rolls out 50M rapid antigen diagnostics
EndpointsSeptember 10, 2020
Totient Partners with Ginkgo Bioworks to Apply Unique Discovery Platform to COVID-19 Antibody Efforts
TotientSeptember 10, 2020
Ginkgo teams with unknown upstart in hunt for Covid-19 antibody
EndpointsAugust 14, 2020
The Plan That Could Give Us Our Lives Back
The AtlanticJuly 31, 2020
This clever COVID-19 testing technique could help send kids back to school safely
Fast CompanyJuly 31, 2020
Ginkgo Bioworks, Mammoth Biosciences among winners of NIH’s ‘Shark Tank’ for Covid-19 tests
STATJuly 31, 2020
Ginkgo Bioworks Awarded $40MM NIH RADx-ATP Contract to Expand High Throughput SARS-CoV-2 Testing
NIH RADxJuly 28, 2020
Boston startups scramble to help employers with on-site COVID-19 testing
Boston GlobeJune 25, 2020
If Biology Can Build It, They Will Come: Ginkgo Bioworks Is Laying The Foundation For The $4 Trillion Bioeconomy
ForbesJune 19, 2020
Ginkgo BioWorks CEO on New Covid-19 Testing Initiative
BloombergJune 18, 2020
Ginkgo Bioworks Launches Concentric by Ginkgo to Help Enable Large-Scale COVID-19 Testing
ConcentricJune 18, 2020
Ginkgo Bioworks CEO on scaling up Covid-19 testing: ‘If we try, we can win’
CNBCMay 28, 2020
Ginkgo raises $70 million to ramp up COVID-19 testing for employers, universities
Boston GlobeMay 28, 2020
Synthetic Bio Pioneer Ginkgo Raises $70 Million to Tackle Covid-19 Testing
BloombergMay 28, 2020
Ginkgo Bioworks to Build Infrastructure for Rapid Epidemic Response with $70MM Investment
Press ReleaseMay 27, 2020
Why Finding The Right Investors Is Critical For Billion-Dollar Success
ForbesApril 30, 2020
Ginkgo Bioworks Redirects Its Biotech Platform to Coronavirus
Wall Street JournalApril 28, 2020
Opinion: The US already has the technology to test millions of people a day
MIT Technology ReviewApril 15, 2020
Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response
ModernaJanuary 21, 2020
Ginkgo Bioworks’ Reshma Shetty On Co-Founding Synthetic Biology’s First Unicorn
ForbesDecember 4, 2019
The Bloomberg 50
Bloomberg BusinessweekNovember 8, 2019
Bloomberg Businessweek Debrief: A Conversation with Jason Kelly
Bloomberg BusinessweekNovember 6, 2019
Ginkgo Bioworks CEO Wants Biology to Manufacture Physical Goods
Bloomberg BusinessweekNovember 1, 2019
Three Industry-Changing Founders on Building Your Own Empire
Marie ClaireOctober 10, 2019
Ginkgo Bioworks to Launch Spinout Companies Through New Fund
The Wall Street JournalOctober 9, 2019
Ginkgo Bioworks raises $350 million fund for biotech spinouts
ReutersOctober 4, 2019
As Silicon Valley faces a tech reckoning, biologists point to the next big opportunity
CNBCSeptember 19, 2019
Ginkgo Bioworks’ dev shop for genetic programming is now worth $4 billion
TechCrunchSeptember 19, 2019
Synthetic Bio Pioneer Ginkgo Raises $290 Million in New Funding
BloombergSeptember 19, 2019
Ginkgo Bioworks Raises $290 Million in Series E Financing to Grow its Platform for Cell Programming
Series E FundraiseSeptember 16, 2019
Silicon Valley’s top startup hub just teamed up with a $1.4 billion company to help startups find new ways of creating drugs, food, and clothing with biology
Business InsiderJuly 25, 2019
Ginkgo Bioworks Co-Founder Honored with Rosalind Franklin Award
Genetic Engineering NewsJuly 24, 2019
The Life Factory: Synthetic Organisms From This $1.4 Billion Startup Will Revolutionize Manufacturing
ForbesJune 13, 2019
Ginkgo Bioworks and Synlogic to collaborate on ‘living medicine’
CNBCJune 12, 2019
Synlogic and Ginkgo Bioworks Establish Transformational Platform Collaboration for the Accelerated Development of Novel Synthetic Biotic™ Medicines
SynlogicMay 30, 2019
BIO Announces 2019 Rosalind Franklin Award Winner: Reshma Shetty, Ginkgo Bioworks
BIOMay 16, 2019
Why Ginkgo Bioworks is number 19 on CNBC’s Disruptor 50 list
CNBCMay 15, 2019
Microbe-Hacker Ginkgo Bioworks Pushes Further Into Medicine With Acquisition Of Genome Mining Platform And Antibiotics Discovery Deal With Roche
ForbesMay 15, 2019
Ginkgo Bioworks Acquires Warp Drive Bio’s Genome Mining Platform for Discovery and Development of Novel Classes of Antibiotics
Warp DriveApril 16, 2019
You Can Now Smell a Flower That Went Extinct a Century Ago
Popular MechanicsApril 16, 2019
Ginkgo Bioworks Appoints Former Bayer CEO Marijn Dekkers as Chairman of its Board of Directors
Press releaseApril 16, 2019
Unilever Chairman Joins Board of Bioengineering Unicorn Ginkgo
BloombergApril 4, 2019
The engineering of living organisms could soon start changing everything
The EconomistFebruary 26, 2019
This food tech startup just raised $90 million to make it easier to invent new plant-based meats
Fast CompanyFebruary 26, 2019
With $90 million in funding, the Ginkgo spinoff Motif joins the fight for the future of food
TechCrunchFebruary 26, 2019
Fund Backed by Bezos, Gates and Ma Invests in Meat Alternatives
BloombergFebruary 26, 2019
Ginkgo Bioworks Launches Motif Ingredients with $90 Million Series A Financing
MotifFebruary 20, 2019
Scent of Extinct Maui Mountain Hibiscus Revived by Science
Maui NowFebruary 1, 2019
Fragrant Genes of Extinct Flowers Have Been Brought Back to Life
Scientific AmericanDecember 21, 2018
This $1 billion start-up backed by Bill Gates prints new DNA — and everyone from the DOD to Bayer is on board
CNBCNovember 8, 2018
Firms invest in human milk oligosaccharides
C&ENNovember 8, 2018
Ginkgo Bioworks and Glycosyn LLC Announce $14MM Deal to Scale Production of Human Milk Oligosaccharides
GlycosynOctober 24, 2018
Ginkgo Bioworks Opens Bioworks4, Adds New Tools for the Rapid Genetic Engineering of Mammalian Cells
Bioworks4October 24, 2018
Ginkgo Bioworks is Turning Human Cells Into On-Demand Factories
WIREDOctober 22, 2018
Cannabis grown from yeast: does the future of pot lie in a lab?
The GuardianSeptember 4, 2018
Cronos Partners With Ginkgo to Develop Lab-Grown Cannabis
BloombergJuly 19, 2018
Ginkgo Bioworks Appoints Claire Laporte as New Head of Intellectual Property
New Head of IPJune 27, 2018
The DNA Cops Who Make Sure the World’s Deadliest Viruses Aren’t Rebuilt
BloombergJune 27, 2018
Ginkgo Bioworks Announces Biosecurity Initiative, Using Deep Learning to Reduce the Global Threat of Biological Weapons and Infectious Disease
Defense WorkJune 14, 2018
Garments of interdependence: Natsai Audrey Chieza on fashion, design, and synthetic biology
SynBioBetaJune 14, 2018
Ginkgo Bioworks Marks 10-Year Anniversary with iGEM Partnership
iGEMJune 7, 2018
Is biological design the future of everything?
Cosmetics DesignMay 31, 2018
Bioengineers Aim to Break Big Ag’s Addiction to Fertilizers
IEEE SpectrumMay 22, 2018
Why Bill Gates is betting on a start-up that prints synthetic DNA
CNBCApril 12, 2018
A controversial technology could save us from starvation — if we let it
Business InsiderApril 12, 2018
Ginkgo Bioworks and Transcriptic selected by DARPA to leverage robotic cloud lab and foundry automation to accelerate biological design with $9.5 M award
SD2March 20, 2018
Bayer and Ginkgo Bioworks Unveil Joint Venture, Joyn Bio, and Establish Operations in Boston and West Sacramento
JoynFebruary 20, 2018
The Billion-Dollar Startups Revolutionizing Healthcare You Should Be Watching in 2018
Business InsiderFebruary 20, 2018
The World’s Most Innovative Companies 2018
Fast CompanyFebruary 20, 2018
Can This Company Convince You to Love GMOs?
The AtlanticFebruary 20, 2018
Bayer Betting Plants Can Fertilize Themselves
BloombergFebruary 20, 2018
Ginkgo Bioworks secures $275 million in Series D, valuing the company at over $1 billion
TechCrunchFebruary 20, 2018
Hundreds Of Millions Of Dollars Pour Into Hacking Microbes
ForbesDecember 14, 2017
Ginkgo Bioworks Launches New Organism Foundry, Supported by $275 Million in Series D Funding
Bioworks 3 Series DDecember 8, 2017
Synlogic and Ginkgo Bioworks Announce Collaboration as First Step Toward Building an Unprecedented Discovery Engine for Novel Living Medicines in Neurological and Liver Disorders
SynlogicOctober 24, 2017
Bayer And Ginkgo Bioworks, A Startup, Aim To Make Crops Produce Their Own Nitrogen Fertilizer
ForbesOctober 24, 2017
This Startup Is Engineering Crops That Can Fertilize Themselves
Fast CompanyOctober 3, 2017
Ginkgo Bioworks Taps Transcriptic’s Robotics Software to Further Accelerate Automation in Organism Design
TranscripticSeptember 15, 2017
Bayer joins in $100 million investment bet on ag-biotech startup
ReutersSeptember 15, 2017
With designer bacteria, crops could one day fertilize themselves
WIREDSeptember 14, 2017
Bayer and Ginkgo Bioworks join forces for sustainable agriculture, forming new company with USD 100 million Series A
Bayer JVAugust 28, 2017
The big business of enzymes
AxiosAugust 28, 2017
New natural selection: How scientists are altering DNA to genetically engineer new forms of life
NewsweekAugust 28, 2017
In this South Boston lab, scientists work alongside robots
The Boston GlobeAugust 28, 2017
Fragrance ingredients made via fermentation have arrived on a commercial scale
Cosmetics Design USAJuly 27, 2017
Ginkgo Bioworks and Kerry Announce New Technology Partnership
KerryMay 18, 2017
Ginkgo Bioworks Disrupting DNA
CNBCMarch 15, 2017
How DNA Could One Day Rebuild Cell Phones
BloombergJanuary 20, 2017
Boston-based Ginkgo snaps up George Church-founded DNA maker
Boston Business JournalJanuary 20, 2017
Ginkgo Bioworks Acquires Leading Synthetic DNA Provider Gen9
Gen9January 13, 2017
Tom Knight’s Ginkgo Bioworks Seeks To Reinvent Moore’s Law Through Biochemistry
ForbesJanuary 4, 2017
The Quest To Bring Biodesign To The Masses
Fast CompanyOctober 10, 2016
Inside South Boston’s new organism factory
Crain's BostonOctober 7, 2016
Cutting Edge: Boston start-up customizes cells to make natural flavors, fragrances
WCVB Channel 5 BostonOctober 7, 2016
Cutting Edge: Boston start-up customizes cells to make natural flavors, fragrances
WCVBOctober 3, 2016
Ginkgo signs trio of microbe deals
c&enSeptember 29, 2016
Ginkgo Builds Out Robot Labs as Microbe Design Business Grows
exomeSeptember 29, 2016
Ginkgo Bioworks Unveils Next Generation Organism Foundry to Bring Biotech into New Markets
Bioworks2September 19, 2016
CRISPR Could Usher In a New Era of Delicious GMO Foods
The AtlanticSeptember 14, 2016
A biotech brew for the scientifically thirsty
The Boston GlobeAugust 15, 2016
Why the Pentagon is paying nearly $2 million for a custom-designed bacteria
CNBCAugust 4, 2016
How Scientists Plan to Grow Cities Out of Living Organisms
GizmodoJuly 23, 2016
Field of genes: Cultivating biopharma, bio-ag links
The Boston GlobeJuly 11, 2016
Commercialization of bio-based products the focus for Ginkgo Bioworks and Amyris partnership
Bio-Based World NewsJune 8, 2016
Ginkgo lands at 7 on CNBC’s disruptor list
CNBCJune 8, 2016
Boston Startup Raises $100 Million To Use Synthetic Biology To Design Microbes For Industry
ForbesJune 8, 2016
Ginkgo Bioworks Secures $100 Million Series C Investment
Series C financingJune 7, 2016
Meet the 2016 CNBC Disruptor 50 Companies
CNBCMay 16, 2016
I Run a G.M.O. Company — and I Support G.M.O. Labeling
The New York TimesApril 7, 2016
12 Women Leading the Life Sciences Movement in Silicon Valley
TechCrunchJanuary 7, 2016
The Science of Senses
WGBHNovember 18, 2015
Move Over, Jony Ive—Biologists Are the Next Rock Star Designers
WiredNovember 7, 2015
Y Combinator’s Sam Altman Is Bullish on Biotech Startups
WiredNovember 4, 2015
Synthetic biology lures Silicon Valley investors
NatureNovember 4, 2015
Twist Bioscience Inks Deal To Sell 100 Million Base Pairs of Synthetic DNA
Fast CompanyNovember 3, 2015
Are microbes about to remake manufacturing? This synthetic biologist thinks so
GristNovember 3, 2015
Ginkgo Bioworks and Robertet to develop new fragrance ingredients
Cosmetics DesignOctober 27, 2015
We sampled fragrances made from microbes and we’re convinced they’re the future of the industry
Business InsiderAugust 26, 2015
Ajinomoto Co., Inc. Partners With Ginkgo Bioworks in Organism Design
AjinomotoJuly 23, 2015
This company is engineering the next sweetener from yeast
FortuneJuly 23, 2015
Ginkgo Bioworks Takes On Zymergen With $45 Million In Series B Funding
TechCrunchJuly 23, 2015
Ginkgo Bioworks Secures $45 Million from Viking Global, OS Fund, Y Combinator and Felicis Ventures
Series BMay 1, 2015
Trailblazing Women: Reshma Shetty, Co-founder of Gingko Bioworks
The Huffington PostMarch 26, 2015
Why organism engineering could be a foodie’s dream come true
The Washington PostMarch 22, 2015
Manufacturing’s Cutting edge—Custom Organisms
The Boston GlobeMarch 18, 2015
This Startup Is Designing Yeast To Make Brand-New Scents, Flavors
BuzzFeedMarch 18, 2015
Ginkgo Bioworks Raises $9M to ‘Engineer’ Food Flavors, Fragrances
The Wall Street JournalMarch 18, 2015
Ginkgo Bioworks Raises $9 Million in Funding from Felicis Ventures, OS Fund and Data Collective
Series AMarch 5, 2015
A Perfume That Smells Like Roses—But Is Actually Made from Yeast
GizmodoDecember 18, 2014
The Quest To Reproduce The Scent Of A Rose, With Designer Microbes
Fast Co.ExistJuly 16, 2014
Why The First YC-Backed Biotech Company May Just Be The Future Of Pharma
TechCrunch
Press Inquiries?
For press inquiries, please email us at [email protected]
